Skip to main content
OpenTrials

Clinical trial condition

Mucinoses

Explore clinical trials studying Mucinoses. Study availability and eligibility vary by location and protocol.

239 public trials 34 recruiting studies
Refine in advanced search Browse all conditions

Mucinoses trial results

Completed

Respiratory Cathepsins, Proteases Inhibitors and Glycosaminoglycans (GAG) in Mucopolysaccharidosis

NCT04112602

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +8 more
Locations
  • Metabolic Disease Competence Centre - Medical Genetics Department - University Hospital, Angers Angers, France
  • Metabolic Disease Reference Centre - Medical Genetics Department - University Hospital, Bordeaux Bordeaux, France
  • Metabolic Disease Competence Centre - Medical Genetics Department - University Hospital, Brest Brest, France
  • Metabolic Disease Competence Centre - Pediatrics Department - University Hospital, Rennes Rennes, France
View Trial Details
Completed

A Study to Assess the Safety and Tolerability of SOBI003 in Pediatric MPS IIIA Patients

NCT03423186

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +10 more
Locations
  • Childrens's Hospital and Research Center Oakland, California, United States
  • University of North Carolina Hospitals Chapel Hill, North Carolina, United States
  • University Medical Center Hamburg-Eppendorf Hamburg, Germany
  • Gazi University Hospital Ankara, Turkey (Türkiye)
View Trial Details
Completed

Long-Term Efficacy and Safety Extension Study of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome)

NCT01415427

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +12 more
Locations
  • Phoenix, Arizona, United States
  • Oakland, California, United States
  • Orange, California, United States
  • Wilmington, Delaware, United States
View all 43 locations
View Trial Details
Completed

A Safety and Dose Ranging Study of Idursulfase (Intrathecal) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Hunter Syndrome Who Have Central Nervous System Involvement and Are Receiving Treatment With Elaprase®

NCT00920647

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +23 more
Locations
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
  • Birmingham Children's Hospital Birmingham, United Kingdom
  • Birmingham Children's Hospital NHS Foundation Trust Birmingham, United Kingdom
View Trial Details

Related conditions